NCT00324038View on ClinicalTrials.gov

Buprenorphine in the Treatment of Osteoarthritis (OA) in the Elderly

PHASE4CompletedINTERVENTIONAL
Enrollment

219

Participants

Timeline

Start Date

March 31, 2006

Study Completion Date

December 31, 2007

Conditions
Osteoarthritis
Interventions
DRUG

Buprenorphine

buprenorphine transdermal system 5, 10 and 20 mg

DRUG

Codeine paracetamol

combination tablet of codeine and paracetamol taken orally 3 or 4 times daily. Dosage form ranges from 8/500, 15/500 and 30/500

Trial Locations (1)

CB4 0GW

Napp Pharmaceuticals Ltd, Cambridge

Sponsors
All Listed Sponsors
lead

Napp Pharmaceuticals Limited

INDUSTRY